Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molecular expression systems for anti-DNA antibodies--2.

S Kumar1, J K Kalsi, C T Ravirajan

  • 1Centre for Rheumatology, Bloomsbury Rheumatology Unit, Department of Medicine, University College London Hospital, London, UK. sanjeev.kumar@antisoma.com

Lupus
|January 17, 2003
PubMed
Summary

Antibodies targeting double-stranded DNA are key markers for lupus nephritis. Understanding their structure is crucial for developing targeted therapies against these pathogenic autoantibodies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sjögren's Systemic Clinical Activity Index (SCAI)--a systemic disease activity measure for use in clinical trials in primary Sjögren's syndrome.

Rheumatology (Oxford, England)·2007
Same author

BILAG, SLEDAI, SIS, ECLAM, WAM, SLAM .... thank you MAM.

Lupus·2007
Same author

B cell depletion therapy in systemic lupus erythematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response.

Annals of the rheumatic diseases·2007
Same author

B cell depletion therapy for patients with systemic lupus erythematosus results in a significant drop in anticardiolipin antibody titres.

Annals of the rheumatic diseases·2007
Same author

Antibodies toward high-density lipoprotein components inhibit paraoxonase activity in patients with systemic lupus erythematosus.

Annals of the New York Academy of Sciences·2007
Same author

Muscular dystrophy mimicking refractory idiopathic inflammatory myositis: a trio of cases.

Rheumatology (Oxford, England)·2007

Area of Science:

  • Immunology
  • Structural Biology
  • Molecular Medicine

Background:

  • Antibodies to double-stranded DNA (anti-dsDNA) are serological markers for systemic lupus erythematosus (SLE), linked to kidney disease.
  • The precise mechanisms by which these antibodies recognize DNA remain unclear.
  • Elucidating the structure-function relationship of anti-dsDNA antibodies is vital for understanding their pathogenicity.

Purpose of the Study:

  • To review recent advancements in over-expressing anti-dsDNA antibody fragments.
  • To facilitate structural studies of these antibodies and their complexes with DNA.
  • To enable the development of novel therapeutic strategies targeting protein-nucleic acid interactions in SLE.

Main Methods:

  • Focus on heterologous cell expression systems for antibody fragment production.

Related Experiment Videos

  • Discuss purification techniques to achieve homogeneous antibody preparations.
  • Highlight the importance of crystallization for detailed three-dimensional structure determination.

    • Main Results:

    • Recent developments enable the production of sufficient quantities of anti-dsDNA antibody fragments for structural analysis.
    • Over-expression in heterologous systems overcomes challenges associated with difficult-to-express DNA-binding antibodies.
    • Purified antibody fragments are suitable for crystallization and subsequent structural studies.

    Conclusions:

    • Successful over-expression and purification of anti-dsDNA antibody fragments are prerequisites for structural studies.
    • Structural insights will illuminate auto-antibody-nucleic acid interactions and pathogenicity.
    • This work supports the development of specific therapies for systemic lupus erythematosus.